1.57 USD
↘ 0.03 (1.88%)PRE MARKET (AS OF 08:38 AM EDT)
Pacific Biosciences of California, Inc.
PACBNASDAQ • USD
Market: OPEN
Pacific Biosciences of California, Inc. (PACB) is currently trading at $1.57. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, PACB trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jun 25, 2026.
Open?$1.57
High?$1.59
Low?$1.52
Prev. Close?$1.60
Volume?19.6K
Avg. Volume?6.0M
VWAP?$1.56
Rel. Volume?0.00x
Bid / Ask
Bid?$1.36 × 100
Ask?$1.83 × 100
Spread?$0.47
Midpoint?$1.60
Valuation & Ratios
Market Cap?497.0M
Shares Out?310.6M
Float?259.7M
Float %?86.0%
P/E Ratio?N/A
P/B Ratio?210.04
EPS?-$0.41
Dividend?0.00%
Ex-Dividend?N/A
RelatedTXG
News
Profile
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
Employees
485
Market Cap
447.3M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
Listed
2010-10-27
Address
1305 O'BRIEN DRIVE
MENLO PARK, CA 94025
Phone: 650-521-8000
MENLO PARK, CA 94025
Phone: 650-521-8000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?86
Short Sent.?55
Piotroski F-Score?3/9Weak
Altman Z-Score?-4.58Distress
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?23.32%Squeeze Risk
Short Interest?60.6M
Days to Cover?10.2
Free Float259.7M
Avg Daily Volume6.0M
Settlement Date2026-06-15
Financial Health
Current Ratio?5.65Strong
Quick Ratio?4.87Strong
Cash Ratio?0.86Adequate
Debt/Equity?272.23High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?210.04HIGH▾
Peers50
S&P3
P/S?3.11FAIR▾
Peers100
S&P49
P/FCF?N/A▾
EV/EBITDA?-7.3CHEAP▾
S&P97
EV/Sales?6.78HIGH▾
Peers50
S&P21
Returns & Efficiency
ROE?-5,434.3%WEAK▾
S&P3
ROA?-16.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-134912000
Enterprise Value?$1.1B
Fundamentals ratios updated end of day